Stockscreener 앱 받기
5.81
11.52%
0.60
시간 외 거래:
5.82
0.01
+0.17%
전일 마감가:
$5.21
열려 있는:
$5.35
하루 거래량:
281.85K
Relative Volume:
0.97
시가총액:
$153.59M
수익:
$50.14M
순이익/손실:
$-35.38M
주가수익비율:
-4.15
EPS:
-1.4
순현금흐름:
$-39.46M
1주 성능:
+8.60%
1개월 성능:
+12.38%
6개월 성능:
-31.49%
1년 성능:
-41.37%
1일 변동 폭
$5.325
$5.91
1주일 범위
$5.0327
$5.91
52주 변동 폭
$4.71
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
RCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.81 | 141.43M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
AVITA Medical Inc. Stock Analysis and ForecastExceptional profit velocity - jammulinksnews.com
Why AVITA Medical Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser
Is AVITA Medical Inc. a good long term investmentMassive profits - Autocar Professional
What analysts say about AVITA Medical Inc. stockFastest return on investment - PrintWeekIndia
What drives AVITA Medical Inc. stock priceBreakthrough capital growth - jammulinksnews.com
Will AVITA Medical Inc. stock benefit from AI tech trendsFree Expert-Led Investment Training - beatles.ru
(RCEL) Trading Signals - news.stocktradersdaily.com
why avita medical inc. stock attracts strong analyst attentionPredictable Return Stock Picks - Newser
What makes AVITA Medical Inc. stock price move sharplyFree Real-Time Stock Data - Newser
How AVITA Medical Inc. stock performs during market volatilityTop ROI Selections - Newser
When Can We Expect A Profit From AVITA Medical, Inc. (NASDAQ:RCEL)? - simplywall.st
Wealth Enhancement Advisory Services LLC Buys 2,564 Shares of Avita Medical Inc. (NASDAQ:RCEL) - Defense World
Ask the analyst: Can ASX growth story turn a profit before it’s too late? - Morningstar
Healthcare Stocks to Watch: Catalyst Pharmaceuticals, AVITA Medical, and Moleculin Biotech. - AInvest
AVITA Medical's High-Stakes Gamble: Can Break-Even Ambitions Outweigh the Debt? - AInvest
(RCEL) Trading Report - news.stocktradersdaily.com
Translational Regenerative Medicine Market Is Booming So - openPR.com
Cantor Fitzgerald Predicts AVITA Medical FY2026 Earnings - MarketBeat
AVITA Medical (RCEL) Receives Continued 'Buy' Rating from D. Bor - GuruFocus
Millennium Management LLC Makes New $426,000 Investment in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Says Data Show Recell Reduced Length of Hospital Stay for Burn Patients - MarketScreener
AVITA Medical Highlights Largest Real-World Analysis Demonstrati - GuruFocus
AVITA Medical (RCEL) Reports Significant Benefits of RECELL Technology in Burn Treatment | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL - The Manila Times
New Data: Revolutionary RECELL Treatment Cuts Hospital Stays by 35%, Saves Hospitals $300M in Burn Care - Stock Titan
Cantor Fitzgerald maintains Avita Medical at Overweight, $19 target By Investing.com - Investing.com Canada
AVITA Medical's (RCEL) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
AVITA Medical (NASDAQ:RCEL) Given “Buy” Rating at D. Boral Capital - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Short Interest Up 23.9% in May - MarketBeat
RCEL: AVITA Medical Maintains Buy Rating with $19 Price Target | RCEL Stock News - GuruFocus
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - The Manila Times
Avita Medical (RCEL) Unveils Promising Results for Cohealyx in Wound Treatment | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care - Investing.com
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care By Investing.com - Investing.com UK
Breakthrough: New Clinical Data Shows AVITA's Wound Treatment Heals 4x Faster Than Standard Care - Stock Titan
BNP Paribas Financial Markets Takes Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Stockholders Approve Key Amendments and Elections - TipRanks
Transcript : AVITA Medical, Inc.Shareholder/Analyst Call - MarketScreener
(RCEL) Investment Report - news.stocktradersdaily.com
AVITA Medical, Inc. (NASDAQ:RCEL) Shares Purchased by Ameriprise Financial Inc. - Defense World
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards - Yahoo Finance
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards | RCEL Stock News - GuruFocus
No normal is the new normal - The Globe and Mail
Revolutionary Wound Care Tech RECELL Crowned Best Surgical Innovation: How 30,000 Patients Benefited - Stock Titan
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.64%
0.34%
자본화:
|
볼륨(24시간):